Venture capital firm Qiming Venture Partners has participated in financing rounds for three China-based companies: personal finance mobile app developer Hangzhou Wacai Science (Wacai), biopharmaceutical company CANbridge Life Sciences and NoSQL database provider SequoiaDB. Qiming participated in a US$50 million Series B financing round for Wacai, which was led by private equity firm China Broadband Capital and CICC Capital, a private equity arm of China International Capital Corporation. Venture capital firms IDG Capital Partners and CDH Ventures also participated in the round. Separately, Qiming led US$10 million Series A financing rounds for both CANbridge Life Sciences and Sequoia DB, with one additional investor, venture capital firm TF Capital, participating in the round for CANbridge Life Sciences.